Far upstream element-binding protein 1 (FUBP1) is overexpressed in human gastric cancer tissue compared to non-cancerous tissue

Onkologie(Czech Republic)

Volumn 36, Issue 11, 2013, Pages 650-655

  Zhang, Fucheng ^a   Tian, Qin ^a   Wang, Yaojun ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Chronic atrophic gastritis; Chronic superficial gastritis; Dysplasia; FUBP1; Gastric cancer

Indexed keywords

BINDING PROTEIN; FAR UPSTREAM ELEMENT BINDING PROTEIN 1; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER TISSUE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GASTRITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER;

ADULT; AGED; CHINA; DNA HELICASES; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PREVALENCE; RISK ASSESSMENT; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84888327880     PISSN: 0378584X     EISSN: 14230240     Source Type: Journal    
DOI: 10.1159/000355659     Document Type: Article

References (29)

1. Karam SM: Cellular origin of gastric cancer. Ann N Y Acad Sci 2008;1138:162-168.
2. Ichikawa D, Kubota T, Kikuchi S, Fujiwara H, Konishi H, Tsujiura M, Ikoma H, Nakanishi M, Okamoto K, Sakakura C, Ochiai T, Kokuba Y, Otsuji E: Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer. J Surg Oncol 2009;100:111-114.
3. Lee HJ, Nam KT, Park HS, Kim MA, Lafleur BJ, Aburatani H, Yang HK, Kim WH, Goldenring JR: Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer. Gastroenterology 2010;139: 213-225.e3.
4. Wanajo A, Sasaki A, Nagasaki H, Shimada S, Otsubo T, Owaki S, Shimizu Y, Eishi Y, Kojima K, Nakajima Y, Kawano T, Yuasa Y, Akiyama Y: Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer. Gastroenterology 2008; 135:580-590.
5. Khanand FA, Shukla AN: Pathogenesis and treatment of gastric carcinoma: 'an up-date with brief review'. J Cancer Res Ther 2006;2:196-199.
6. Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS: Biologic predictors of survival in node-negative gastric cancer. Ann Surg 2003;237: 828-835; discussion 835-827.
7. Zubaidah RM, Tan GS, Tan SB, Lim SG, Lin Q, Chung MC: 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis. Proteomics 2008;8: 5086-5096.
8. Rabenhorst U, Beinoraviciute-Kellner R, Brezniceanu ML, Joos S, Devens F, Lichter P, Rieker RJ, Trojan J, Chung HJ, Levens DL, Zornig M: Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth. Hepatology 2009;50:1121-1129.
9. Sanderson LM, Boekschoten MV, Desvergne B, Muller M, Kersten S: Transcriptional profiling reveals divergent roles of PPARalpha and PPARbeta/delta in regulation of gene expression in mouse liver. Physiol Genomics 2010;41:42-52.
10. Chen M, Zhang J, Li N, Qian Z, Zhu M, Li Q, Zheng J, Wang X, Shi G: Promoter hypermethyl-ation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer. PloS One 2011;6:e25564.
11. Weber A, Kristiansen I, Johannsen M, Oelrich B, Scholmann K, Gunia S, May M, Meyer HA, Behnke S, Moch H, Kristiansen G: The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer. BMC Cancer 2008;8:369.
12. Singer S, Malz M, Herpel E, Warth A, Bissinger M, Keith M, Muley T, Meister M, Hoffmann H, Penzel R, Gdynia G, Ehemann V, Schnabel PA, Kuner R, Huber P, Schirmacher P, Breuhahn K: Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer. Cancer Res 2009;69:2234-2243.
13. Gagne JP, Gagne P, Hunter JM, Bonicalzi ME, Lemay JF, Kelly I, Le Page C, Provencher D, Mes- Masson AM, Droit A, Bourgais D, Poirier GG: Proteome profiling of human epithelial ovarian cancer cell line TOV-112D. Mol Cell Biochem 2005;275:25-55.
14. Bettegowda C, Agrawal N, Jiao Y, Sausen M, Wood LD, Hruban RH, Rodriguez FJ, Cahill DP, McLendon R, Riggins G, Velculescu VE, Oba- Shinjo SM, Marie SK, Vogelstein B, Bigner D, Yan H, Papadopoulos N, Kinzler KW: Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 2011;333:1453-1455.
15. Engidawork E, Afjehi-Sadat L, Yang JW, Slavc I, Lubec G: Protein chemical identification and characterization of the human variants of far upstream element binding protein in medulloblastoma DAOY cell line. Int J Oncol 2006;29:721-736.
16. Luo Z, Zhang Q, Zhao Z, Li B, Chen J, Wang Y: OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer. J Cancer Res Clin Oncol 2011;137:1713-1720.
17. Busuttiland RA, Boussioutas A: Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J Gastroenterol Hepatol 2009;24: 193-201.
18. Hundahl SA, Phillips JL, Menck HR: The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the 'different disease' hypothesis. Cancer 2000;88:921-932.
19. Correa P: Is gastric cancer preventable? Gut 2004; 53:1217-1219.
20. Yamashita K, Sakuramoto S, Watanabe M: Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications. Surg Today 2011;41:24-38.
21. He L, Liu J, Collins I, Sanford S, O'Connell B, Benham CJ, Levens D: Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression. EMBO J 2000;19:1034-1044.
22. He L, Weber E, Levens D: Nuclear targeting determinants of the far upstream element binding protein, a c-myc transcription factor. Nucleic Acids Res 2000;28:4558-4565.
23. Malz M, Weber A, Singer S, Riehmer V, Bissinger M, Riener MO, Longerich T, Soll C, Vogel A, Angel P, Schirmacher P, Breuhahn K: Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells. Hepatology 2009; 50:1130-1139.
24. Lu HN, Zhang FC, Wang YJ: (The effect of far upstream element binding protein-1 on the pathogenesis of human hepatocellular carcinomas). Zhonghua Gan Zang Bing Za Zhi 2011;19:696-698.
25. Rappsilber J, Ryder U, Lamond AI, Mann M: Large-scale proteomic analysis of the human spliceosome. Genome Res 2002;12:1231-1245.
26. Jang M, Park BC, Kang S, Chi SW, Cho S, Chung SJ, Lee SC, Bae KH, Park SG: Far upstream element-binding protein-1, a novel caspase substrate, acts as a cross-talker between apoptosis and the c-myc. Oncogene 2009;28:1529-1536.
27. Chungand HJ, Levens D: c-myc expression: keep the noise down! Mol Cells 2005;20:157-166.
28. Kim MJ, Park BJ, Kang YS, Kim HJ, Park JH, Kang JW, Lee SW, Han JM, Lee HW, Kim S: Downregulation of FUSE-binding protein and c-myc by tRNA synthetase cofactor p38 is required for lung cell differentiation. Nat Genet 2003;34: 330-336.
29. Huth JR, Yu L, Collins I, Mack J, Mendoza R, Isaac B, Braddock DT, Muchmore SW, Comess KM, Fesik SW, Clore GM, Levens D, Hajduk PJ: NMRdriven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter. J Med Chem 2004;47:4851-4857.